ICEMEDX Health News™

Nigerian Government sets up traditional medicine department - Date: June 28, 2018

The Nigerian Federal Government has approved the establishment of Department of Traditional and Alternative Medicine in the Federal Ministry of Health. This approval was given by the Office of the Head of Service. The department will regulate the activities of alternative medicine practitioners. Hon Min. Prof. Adewole informed the council that "the new department will provide leadership in our effort to give prominence to traditional medicine in Nigeria. The government has now launched the second National Strategic Health Development plan to deepen healthcare service delivery. The new five-year plan will run from 2018-2028, the previous plan ended in 2015. This five-year plan will help foster efficient healthcare service across the country. The goal is to increase access to healthcare by providing universal health coverage and improve health outcomes for all Nigerians.

Could a new typhoid vaccine end the most misdiagnosed disease in Nigeria? - Date: June 27, 2018

Typhoid fever has been known as one of the most diagnosed diseases in a Nigeria. Typhoid fever is a life-threatening infection caused by the bacterium Salmonella Typhi. It is spread though food or water with symptoms that include the following: prolonged fever, fatigue, headache, nausea and abdominal pain. The major risk factors for the transmission of typhoid fever are unhygienic conditions, poor access to clean drinking water and toileting facilities. These are circumstances that still exist widely in Nigeria. If Typhoid fever is misdiagnosed, it can lead to many harmful and life-threating outcomes. This new vaccine is roughly 87% effective in preventing typhoid fever. Presently, the Typhoid vaccine can only be used in toddlers starting at age 24 months. However, Nigeria can now offer infants protection against Typhoid fever earlier than 6 months of age.

Will self-testing lead to better access to HIV treatment in Nigeria? - Date: June 21, 2018

Africa still faces the challenge of fighting HIV. Current estimates state that there are over 3 million Nigerians living with HIV. The World Health Organization (WHO) recommends that everyone with HIV should have access to antiretroviral therapy. In 2016, a report on HIV/AIDS showed that about 40% of the estimated 36.7 million people living with HIV were unaware of being infected. In 2014, an ambitious new 90-90-90 target to end AIDS was launched by the United Nations AID Program on HIV/AIDS. The goal was to ensure that by the year 2020, 90% of people living with HIV worldwide would know their HIV status. In Nov 2016, to improve access to HIV treatment, the WHO issued a new guidance on HIV self-testing. People will be able to use oral swabs or blood from finger pricks to check their own HIV status in a private and convenient setting and receive their HIV status results within 20 minutes.

World Health Organization (WHO) introduces 5 new Ebola drugs in the Democratic of Congo (DRC) - Date: June 6, 2018

WHO introduced five new investigational therapeutics to treat Ebola following an outbreak of Ebola in the DRC. The following drugs have been approved by the DRC: Zmapp, GS-5734, REGN monoclonal antibody combination, mAb114. Zmapp an experimental biopharmaceutical drug with monoclonal antibodies, GS-5734 antiviral drug and mAb114 which protects nonhuman primates against Ebola. After getting informed consent from human patients, clinics will administer these experimental drugs on their patients to determine the best treatment outcomes. Since Ebola has such a high mortality rate, the WHO will shorten the clinical trials process and use these pharmaceutical treatments in current Ebola patients. It has been reported that there are currently 58 EVD cases, including 27 deaths, 37 lab-confirmed, 14 probable and 7 suspected cases.

Maitama Hospital Measles and Yellow Fever Laboratory gets a boost from the World Health Organization (WHO) - Date: May 17, 2018

The WHO has refurbished a porta cabin work space in Maitama General Hospital in Abuja, Nigeria with ELISA readers and microplate washers to improve the quality of research for their measles and yellow fever surveillance unit. Measles is a preventable viral disease and one of the major causes of childhood morbidity and mortality in developing countries. The disease is being targeted for elimination by countries in Nigeria and globally. Quality measles surveillance is essential to achieving elimination; and a functioning measles research laboratory is an important component of measles surveillance. WHO has provided support (buildings, supplies, equipment etc.) to four national measles and yellow fever laboratories in Nigeria since 2006.

Copyright © 2003 - 2019 ICEMEDX, Inc.          ICEMEDX ICEMEDX      Privacy Policy      Meaningful Use